The Scleroderma Tango: Unraveling the Delicate Dance of Diastolic Dysfunction and Interstitial Lung Disease

J Rheumatol. 2024 Mar 1:jrheum.2024-0154. doi: 10.3899/jrheum.2024-0154. Online ahead of print.ABSTRACTIn this issue of The Journal of Rheumatology, Fairley and colleagues investigated the effects of concomitant left ventricular diastolic dysfunction (LVDD) in a small cohort of patients with systemic sclerosis (SSc)-associated interstitial lung disease (ILD) derived from the larger Australian Scleroderma Cohort Study.1 Consistent with prior reports, the authors found that patients with SSc-ILD with LVDD experienced dyspnea and reduced survival. In addition, these patients were older, had longer SSc disease duration exceeding 6 years, received treatment with immunosuppressive drugs, and had additional cardiovascular (CV) comorbidities.PMID:38428962 | DOI:10.3899/jrheum.2024-0154
Source: J Rheumatol - Category: Rheumatology Authors: Source Type: research